Chemical Identity and Physical Properties

Taurodeoxycholic acid (TDCA) is the taurine conjugate of deoxycholic acid, formed by an amide bond between the carboxyl group of deoxycholic acid and the amino group of taurine. Its molecular formula is C₂₆H₄₅NO₆S, with a molecular weight of approximately 499.70 g/mol. Like other bile salts, TDCA is amphipathic: it possesses a hydrophobic steroid nucleus and a hydrophilic sulfonate-terminated side chain, conferring strong detergent properties and high aqueous solubility at physiological pH.

TDCA is typically supplied as a white to off-white powder. It is freely soluble in water and aqueous buffers, making it easy to formulate for cell-based and biochemical assays. The compound is stable when stored under recommended conditions (typically desiccated, protected from light, at −20 °C for long-term storage). Researchers should consult the specific product specification sheet for lot-dependent purity data, which for research-grade material commonly exceeds 98% by HPLC.

Biological Roles and Mechanism of Action

TDCA is classified as a secondary bile acid because it is derived from the primary bile acid cholic acid through two sequential microbial transformations in the colon: first, bacterial enzymes deconjugate taurocholic acid to release deoxycholic acid, and second, re-conjugation with taurine can regenerate TDCA. The gut microbiome—particularly anaerobic bacteria of the genera Clostridium and Bacteroides—plays a critical role in controlling the pool of secondary bile acids including TDCA.

In the intestinal lumen, TDCA participates in the emulsification of dietary fats and cholesterol, facilitating their absorption by forming mixed micelles with phospholipids and monoglycerides. Beyond digestion, TDCA and related bile acids act as signaling molecules. They activate nuclear receptors such as the farnesoid X receptor (FXR) and membrane receptors such as TGR5 (GPBAR1), thereby influencing glucose homeostasis, energy expenditure, inflammation, and intestinal barrier integrity. Dysregulation of the secondary bile acid pool, including altered TDCA levels, has been associated with metabolic syndrome, colorectal cancer risk, and inflammatory bowel disease in preclinical models.

Research Applications

TDCA is used across a wide range of in vitro and in vivo experimental contexts:

• Gut microbiome studies: TDCA serves as a substrate or readout molecule in assays probing bile salt hydrolase (BSH) activity and bacterial bile acid metabolism. It is used to challenge microbial communities in culture and assess community-level metabolic capacity.
• Receptor pharmacology: TDCA is employed as a tool compound to interrogate FXR and TGR5 signaling, often in comparison with other natural and synthetic bile acid ligands.
• Cell biology and cytotoxicity: At supraphysiological concentrations, bile acids including TDCA induce apoptosis and necrosis in intestinal epithelial cells, making TDCA a useful model compound for studying bile acid-induced cellular stress and barrier dysfunction.
• Metabolomics: TDCA is frequently included in targeted metabolomics panels for serum, plasma, bile, and fecal samples, serving as a quantitative marker of enterohepatic circulation and microbiome activity.
• Lipid absorption models: TDCA is incorporated into artificial bile formulations used to assess drug solubilization, bioaccessibility, and lipid-based drug delivery systems.

Researchers should confirm the appropriate concentration ranges for each application using validated assay conditions, as effective concentrations vary substantially between cell-free biochemical assays and intact cell or animal models.

Handling, Storage, and Safety Considerations

TDCA should be handled in accordance with standard laboratory safety practices for research-grade biochemicals. Appropriate personal protective equipment—including nitrile gloves, laboratory coat, and safety glasses—should be worn when weighing or preparing solutions. As with other bile acids, TDCA can act as a surfactant and may cause irritation to skin, eyes, and mucous membranes upon direct contact.

For storage, TDCA is recommended to be kept desiccated and protected from light. Short-term storage at 4 °C is acceptable; for long-term preservation of activity and chemical integrity, storage at −20 °C is preferred. Repeated freeze-thaw cycles should be minimized by preparing single-use aliquots of stock solutions. Aqueous stock solutions should be prepared fresh or stored at −20 °C and used within a validated timeframe. Always refer to the Safety Data Sheet (SDS) supplied with the product for comprehensive hazard information and disposal guidance.

Procurement and Aladdin Scientific Product Information

Aladdin Scientific offers taurodeoxycholic acid under SKU T1499611 for research applications. The product is supplied as a solid and is intended for in vitro research use only; it is not approved for use in diagnostic procedures or human/veterinary therapeutics.

When ordering, researchers and procurement teams should verify the required purity grade, pack size, and any certificate of analysis (CoA) requirements relevant to their application. For regulatory-sensitive workflows such as GMP-adjacent research or metabolomics reference standard applications, please contact Aladdin Scientific's technical support team to confirm the most appropriate grade and documentation package. Bulk quantities and custom packaging may be available upon request.

For questions regarding compatibility with specific assay systems, solubility in non-aqueous vehicles, or stability under experimental conditions, Aladdin Scientific's scientific support staff can provide application-specific guidance.